We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$928M
AUM Growth
-$26M
Cap. Flow
-$37.9M
Cap. Flow %
-4.08%
Top 10 Hldgs %
59.54%
Holding
150
New
27
Increased
25
Reduced
20
Closed
35
Avg Time Held
1.9 years
Top 10 Avg Time Held
2 years
Top 20 Avg Time Held
2.3 years

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$9.14M
2
MO icon
Altria Group
MO
+$5.27M
3
JNJ icon
Johnson & Johnson
JNJ
+$3.14M
4
MDT icon
Medtronic
MDT
+$2.37M
5
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.31M

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$16.7M
2
RTX icon
RTX Corp
RTX
+$12.1M
3
GIS icon
General Mills
GIS
+$11M
4
GE icon
GE Aerospace
GE
+$9.69M
5
WFC icon
Wells Fargo
WFC
+$4.61M

Sector Composition

Rank Sector Weight
1 Financials 38.49%
2 Healthcare 20.5%
3 Industrials 9.59%
4 Miscellaneous 9.57%
5 Materials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
ECL icon
76
Ecolab
ECL
$81.5B
$415K 0.04%
2,100
– –
2017 Q2
8 quarters
VKTX icon
77
Viking Therapeutics
VKTX
$3.48B
$415K 0.04%
50,000
– –
2018 Q4
2 quarters
MRSN icon
78
DELISTED
Mersana Therapeutics
MRSN
$365K 0.04%
3,610
– –
2018 Q4
2 quarters
CARM icon
79
DELISTED
Carisma Therapeutics
CARM
$318K 0.03%
10,593
-10
-0.1% -$299
2018 Q3
3 quarters
DO icon
80
DELISTED
Diamond Offshore Drilling
DO
$312K 0.03%
35,200
– –
2014 Q4
18 quarters
ERUS
81
DELISTED
iShares MSCI Russia ETF
ERUS
$309K 0.03%
7,850
– –
2019 Q1
1 quarter
TMO icon
82
Thermo Fisher Scientific
TMO
$258B
$294K 0.03%
+1,000
New +$275K
2019 Q2
0 quarters
ALDX icon
83
Aldeyra Therapeutics
ALDX
$44.5M
$267K 0.03%
44,520
– –
2017 Q1
9 quarters
SPHS
84
DELISTED
Sophiris Bio, Inc.
SPHS
$254K 0.03%
300,900
+100,000
+50% +$87.6K
2018 Q3
3 quarters
EME icon
85
Emcor
EME
$32.3B
$226K 0.02%
+2,570
New +$208K
2019 Q2
0 quarters
FSTX
86
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$226K 0.02%
15,334
+1,950
+15% +$52.2K
2018 Q3
3 quarters
HRB icon
87
H&R Block
HRB
$5.92B
$222K 0.02%
7,590
-2,170
-22% -$58.3K
2018 Q2
4 quarters
MAN icon
88
ManpowerGroup
MAN
$2.03B
$222K 0.02%
+2,300
New +$210K
2019 Q2
0 quarters
COR icon
89
Cencora
COR
$65.2B
$221K 0.02%
+2,590
New +$205K
2019 Q2
0 quarters
PBH icon
90
Prestige Consumer Healthcare
PBH
$2.33B
$220K 0.02%
+6,960
New +$207K
2019 Q2
0 quarters
SYF icon
91
Synchrony
SYF
$24.1B
$218K 0.02%
+6,300
New +$214K
2019 Q2
0 quarters
NKTR icon
92
Nektar Therapeutics
NKTR
$1.29B
$210K 0.02%
+393
New +$197K
2019 Q2
0 quarters
INVA icon
93
Innoviva
INVA
$1.51B
$209K 0.02%
+14,340
New +$203K
2019 Q2
0 quarters
AMAT icon
94
Applied Materials
AMAT
$341B
$208K 0.02%
+4,630
New +$195K
2019 Q2
0 quarters
AEIS icon
95
Advanced Energy
AEIS
$10.1B
$205K 0.02%
+3,650
New +$196K
2019 Q2
0 quarters
MTOR
96
DELISTED
MERITOR, Inc.
MTOR
$205K 0.02%
+8,470
New +$190K
2019 Q2
0 quarters
HPQ icon
97
HP
HPQ
$27.8B
$204K 0.02%
+9,790
New +$194K
2019 Q2
0 quarters
WW icon
98
DELISTED
WW International
WW
$202K 0.02%
+10,600
New +$210K
2019 Q2
0 quarters
CALA
99
DELISTED
Calithera Biosciences, Inc
CALA
$195K 0.02%
2,500
– –
2018 Q2
4 quarters
CORT icon
100
Corcept Therapeutics
CORT
$12.3B
$187K 0.02%
+16,790
New +$187K
2019 Q2
0 quarters
2 3
4
5 6

Similar funds

TPW
Talon Private Wealth The Villages, Florida $855M AUM
EWA
Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $854M AUM 21.01% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $853M AUM 15.61% 1-Year Est. Return
QIM
Quest Investment Management Lake Oswego, Oregon $856M AUM 29.41% 1-Year Est. Return
AIMC
Alley Investment Management Company Lake Forest, Illinois $856M AUM 15.11% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $853M AUM 18.22% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

Hikari Power's Q2 2019 Portfolio in Review

As of Q2 2019, Hikari Power held 150 positions worth $928M, down 2.7% from $954M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Hikari Power withdrew a net $37.9M in Q2 2019, closing 35 positions and reducing 20 holdings. Its most notable exit was Sanofi, an estimated $3.15M position sold in full.

By sector, the portfolio is most concentrated in Financials at 38% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Hikari Power opened a new position in Vanguard Short-Term Bond ETF worth $9.23M.

  • Hikari Power's largest Q2 2019 buy was Vanguard Short-Term Bond ETF: 114,600 shares worth $9.23M.
  • Hikari Power added most to Altria Group in Q2 2019, an estimated $5.27M increase.
  • Hikari Power's biggest Q2 2019 reduction was IBM, cutting an estimated $16.7M.
  • Hikari Power fully exited Sanofi in Q2 2019, selling an estimated $3.15M.
  • Hikari Power's ten largest holdings make up 60% of its $928M portfolio in Q2 2019.
  • Hikari Power opened 27 new positions and closed 35 in Q2 2019.
  • Hikari Power's portfolio value fell 2.7% quarter-over-quarter to $928M.

Based on Hikari Power's 13F filing for Q2 2019, filed 8 Aug 2019.